Last Updated:
NameDesignationAppointment DateStatus
Atul Natwarlal Pandya

Appointed as Director since July 2007

Director31-Jul-2007Current
Hemant Gajanand Upadhyay

Appointed as Director since May 2003

Director31-May-2003Current
Kamal Natwarlal Pandya

Appointed as Director since November 1993

Director16-Nov-1993Current
Parag Vamanray Raval

Appointed as Director since May 2018

Director10-May-2018Current
Rushiraj Atulbhai Pandya

Appointed as Additional Director since March 2025

Additional Director10-Mar-2025Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Pan Drugs Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Pan Drugs Limited's leadership journey.

Loading...
Contact Details
  • Address 301,312 World Trade Center, Sayajigunj, Vadodara Gujarat, 390007, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Pan Drugs Limited through their registered address at 301,312 World Trade Center, Sayajigunj, Vadodara Gujarat, 390007, India, or via their website at pandrugsltd.com. Social media links are also provided where applicable.
The current directors of Pan Drugs Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • ATUL NATWARLAL PANDYA
  • PARAG VAMANRAY RAVAL
  • KAMAL NATWARLAL PANDYA
  • HEMANT GAJANAND UPADHYAY
  • Rushiraj Atulbhai Pandya
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available